Related Experiment Video
Updated: Apr 30, 2026
11:34
High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
Published on: May 5, 2014
13.2K
Interferon-free strategies without a nucleoside/nucleotide analogue
Tania Mara Welzel1, Stefan Zeuzem1
1Department of Medicine 1, JW Goethe University Hospital, Frankfurt am Main, Germany.
Seminars in Liver Disease
|May 1, 2014
Summary
Direct-acting antiviral agents (DAAs) and host-targeting agents (HTAs) offer new hepatitis C virus (HCV) treatments. Interferon-free, all-oral regimens are nearing approval, improving patient outcomes.
Area of Science:
- Hepatology
- Virology
- Pharmacology
Background:
- Hepatitis C virus (HCV) replication involves viral and host factors, crucial for identifying antiviral drug targets.
- Development of direct-acting antiviral agents (DAAs) and host-targeting agents (HTAs) has advanced HCV therapy.
- Pegylated interferon's side effects necessitate the development of novel, interferon-free treatment approaches.
Purpose of the Study:
- To review the development and clinical testing of DAAs and HTAs for HCV.
- To analyze the design and outcomes of DAA combination trials.
- To discuss the progression towards all-oral, interferon-free HCV treatment regimens.
Main Methods:
- Review of clinical trial data for DAAs and HTAs.
- Analysis of combination therapy trials, excluding nucleos(t)ide polymerase inhibitors.
- Evaluation of studies focusing on host-targeting agents in HCV treatment.
Main Results:
- Numerous DAAs and HTAs have been developed and entered clinical trials.
- Interferon-free regimens are anticipated for approval in 2014/2015.
- DAA combination trials demonstrate progress towards easily applicable, all-oral HCV treatments.
Conclusions:
- DAAs and HTAs represent significant advancements in hepatitis C virus treatment.
- The shift towards interferon-free, all-oral therapies promises improved patient compliance and reduced side effects.
- Ongoing research and clinical trials are paving the way for highly effective HCV eradication.
More Related Videos
Related Concept Videos
01:30Inhibitors of Viral Protein Synthesis
58
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
58
01:29Viruses with RNA Genomes
1.5K
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
1.5K
01:23RNA Interference
24.3K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
24.3K
01:23RNA Interference
6.4K
6.4K
02:15Experimental RNAi
6.5K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.5K
02:30siRNA - Small Interfering RNAs
13.4K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
13.4K